Daxin Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -48.88%
- Profit Growth 38.10%
- Ebitda 38.54%
- Net Worth -10.05%
- Total Assets -3.26%
About Daxin Healthcare
Daxin Healthcare Private Limited (DHPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 February 2017 (Seven years and 11 months 19 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anuradha and Gurubharan Krishnamoorthynagarajan serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999TN2017PTC115057
-
Company No.
115057
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Feb 2017
-
Date of AGM
13 Feb 2024
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Daxin Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anuradha
|
Director | 20-Feb-2017 | Current |
|
Gurubharan Krishnamoorthynagarajan
|
Director | 20-Feb-2017 | Current |
Financial Performance of Daxin Healthcare.
Daxin Healthcare Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 48.88% decrease. The company also saw a substantial improvement in profitability, with a 38.1% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Daxin Healthcare?
In 2022, Daxin Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Deccan Designs (India) Private LimitedAnuradha and Gurubharan Krishnamoorthynagarajan are mutual person
-
Deccan Techlogic Private Limited
Anuradha and Gurubharan Krishnamoorthynagarajan are mutual person
-
Deccan Overseas Exports Private Limited
Gurubharan Krishnamoorthynagarajan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Daxin Healthcare?
Unlock and access historical data on people associated with Daxin Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Daxin Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daxin Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.